| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.39 | 0.003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |